Find out how the Sickle Cell Society's successful partnership work with the NHS Sickle Cell and Thalassaemia Screening Programme makes a difference to the lives of people who live with sickle cell disorders and their families.
John James OBE
John James has 33 years of experience within the NHS including 4 chief executive officer roles. He was Chair of the West London Cancer network (2002 to 2005) and Chair of the North West London Diabetes Network (2003 to 2004). As a senior civil servant for the Department of Health he served as program consultant on leadership for the NHS Next Stage Review and then as Deputy Director for the NHS Medical Director/Director General. He has been Chief Executive of the Sickle Cell Society for the last 5 years. In June 2018, John was awarded an OBE as part of the Queen’s Birthday Honours.
Related content and links
The PHE Screening team
Public Health England (PHE) existed to protect and improve the nation’s health and wellbeing, and reduce health inequalities. It closed on 30 September 2021 and this blog is no longer updated.
Find out more about the implications for health screening in our Changes ahead for the national screening system blog article.
If you want to stay in touch with screening evidence and policy news, you can subscribe to the UK National Screening Committee blog.
Comments and moderation
- Changes ahead for the national screening system 30 September 2021
- What we blogged about in August and September 2021 30 September 2021
- New resources to help improve quality of samples taken in NHS newborn blood spot screening 30 September 2021